225 related articles for article (PubMed ID: 26504856)
21. Prolonged darkness reduces liver fibrosis in a mouse model of primary sclerosing cholangitis by miR-200b down-regulation.
Wu N; Meng F; Zhou T; Han Y; Kennedy L; Venter J; Francis H; DeMorrow S; Onori P; Invernizzi P; Bernuzzi F; Mancinelli R; Gaudio E; Franchitto A; Glaser S; Alpini G
FASEB J; 2017 Oct; 31(10):4305-4324. PubMed ID: 28634212
[TBL] [Abstract][Full Text] [Related]
22. HLA DPB polymorphism in primary sclerosing cholangitis and primary biliary cirrhosis.
Underhill JA; Donaldson PT; Doherty DG; Manabe K; Williams R
Hepatology; 1995 Apr; 21(4):959-62. PubMed ID: 7705806
[TBL] [Abstract][Full Text] [Related]
23. Increased prevalence of CFTR mutations and variants and decreased chloride secretion in primary sclerosing cholangitis.
Sheth S; Shea JC; Bishop MD; Chopra S; Regan MM; Malmberg E; Walker C; Ricci R; Tsui LC; Durie PR; Zielenski J; Freedman SD
Hum Genet; 2003 Aug; 113(3):286-92. PubMed ID: 12783301
[TBL] [Abstract][Full Text] [Related]
24. The role of Helicobacter spp. in the pathogenesis of primary biliary cirrhosis and primary sclerosing cholangitis.
Boomkens SY; de Rave S; Pot RG; Egberink HF; Penning LC; Rothuizen J; Zondervan PE; Kusters JG
FEMS Immunol Med Microbiol; 2005 May; 44(2):221-5. PubMed ID: 15866219
[TBL] [Abstract][Full Text] [Related]
25. Prolonged fibroblast growth factor 19 response in patients with primary sclerosing cholangitis after an oral chenodeoxycholic acid challenge.
Zweers SJ; de Vries EM; Lenicek M; Tolenaars D; de Waart DR; Koelfat KV; Groen AK; Olde Damink SW; Beuers U; Ponsioen C; Jansen PL; Schaap FG
Hepatol Int; 2017 Jan; 11(1):132-140. PubMed ID: 27696157
[TBL] [Abstract][Full Text] [Related]
26. Cholestatic Liver Injury: Care of Patients With Primary Biliary Cholangitis or Primary Sclerosing Cholangitis.
Larson L; James M; Gossard A
AACN Adv Crit Care; 2016 Oct; 27(4):441-452. PubMed ID: 27959300
[TBL] [Abstract][Full Text] [Related]
27. Adhesion molecule expression in primary sclerosing cholangitis and primary biliary cirrhosis.
Bloom S; Fleming K; Chapman R
Gut; 1995 Apr; 36(4):604-9. PubMed ID: 7537707
[TBL] [Abstract][Full Text] [Related]
28. Polymorphisms in the steroid and xenobiotic receptor gene influence survival in primary sclerosing cholangitis.
Karlsen TH; Lie BA; Frey Frøslie K; Thorsby E; Broomé U; Schrumpf E; Boberg KM
Gastroenterology; 2006 Sep; 131(3):781-7. PubMed ID: 16952547
[TBL] [Abstract][Full Text] [Related]
29. Primary sclerosing cholangitis: detailed histologic assessment and integration using bioinformatics highlights arterial fibrointimal hyperplasia as a novel feature.
Carrasco-Avino G; Schiano TD; Ward SC; Thung SN; Fiel MI
Am J Clin Pathol; 2015 Apr; 143(4):505-13. PubMed ID: 25780002
[TBL] [Abstract][Full Text] [Related]
30. Genome-wide resolution peripheral blood methylome profiling reveals signatures for cholestatic liver disease.
Moore RM; Sun Z; Juran BD; Lazaridis KN
Epigenomics; 2020 Aug; 12(16):1363-1375. PubMed ID: 32914644
[No Abstract] [Full Text] [Related]
31. Regulation of 3β-hydroxysteroid dehydrogenase and sulphotransferase 2A1 gene expression in primary porcine hepatocytes by selected sex-steroids and plant secondary metabolites from chicory (Cichorium intybus L.) and wormwood (Artemisia sp.).
Rasmussen MK; Ekstrand B
Gene; 2014 Feb; 536(1):53-8. PubMed ID: 24333270
[TBL] [Abstract][Full Text] [Related]
32. BSEP and MDR3 haplotype structure in healthy Caucasians, primary biliary cirrhosis and primary sclerosing cholangitis.
Pauli-Magnus C; Kerb R; Fattinger K; Lang T; Anwald B; Kullak-Ublick GA; Beuers U; Meier PJ
Hepatology; 2004 Mar; 39(3):779-91. PubMed ID: 14999697
[TBL] [Abstract][Full Text] [Related]
33. [Autoimmune liver diseases and their overlap syndromes].
Strassburg CP
Praxis (Bern 1994); 2006 Sep; 95(36):1363-81. PubMed ID: 16989180
[TBL] [Abstract][Full Text] [Related]
34. Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.
Bell LN; Wulff J; Comerford M; Vuppalanchi R; Chalasani N
Liver Int; 2015 Jan; 35(1):263-74. PubMed ID: 25181933
[TBL] [Abstract][Full Text] [Related]
35. Lack of association of common cystic fibrosis transmembrane conductance regulator gene mutations with primary sclerosing cholangitis.
Gallegos-Orozco JF; E Yurk C; Wang N; Rakela J; Charlton MR; Cutting GR; Balan V
Am J Gastroenterol; 2005 Apr; 100(4):874-8. PubMed ID: 15784035
[TBL] [Abstract][Full Text] [Related]
36. [Cholestatic liver diseases].
Grimm D; Thimme R
Ther Umsch; 2011 Apr; 68(4):195-9. PubMed ID: 21452140
[TBL] [Abstract][Full Text] [Related]
37. Molecular cloning and regulation of porcine SULT2A1: relationship between SULT2A1 expression and sulfoconjugation of androstenone.
Sinclair PA; Gilmore WJ; Lin Z; Lou Y; Squires EJ
J Mol Endocrinol; 2006 Apr; 36(2):301-11. PubMed ID: 16595701
[TBL] [Abstract][Full Text] [Related]
38. The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis.
ter Borg PC; Fekkes D; Vrolijk JM; van Buuren HR
BMC Gastroenterol; 2005 Mar; 5():11. PubMed ID: 15790420
[TBL] [Abstract][Full Text] [Related]
39. Immunolocalization of putative human liver progenitor cells in livers from patients with end-stage primary biliary cirrhosis and sclerosing cholangitis using the monoclonal antibody OV-6.
Crosby HA; Hubscher S; Fabris L; Joplin R; Sell S; Kelly D; Strain AJ
Am J Pathol; 1998 Mar; 152(3):771-9. PubMed ID: 9502419
[TBL] [Abstract][Full Text] [Related]
40. Impact of Microbes on the Pathogenesis of Primary Biliary Cirrhosis (PBC) and Primary Sclerosing Cholangitis (PSC).
Mattner J
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
